Table 1.

Clinical, biological and pathological data for patients with cHL-MCNS

Patients#	1	2	3	4	5	6	7	8
Sex (M/F)	M	M	M	F	M	F	F	M
MCNS occurrence (month/year	07/1999	12/1990	06/1995	05/1995	03/1999	02/2000	06/2002	12/2000
cHL occurrence (month/year)	07/1999	12/1990	09/1995	11/1997	10/1999	08/1997	04/2002	12/2000
Urinary protein (g/day)	16	13.3	17	13	5.36	4.5	3	9
Serum albumin (g/l)	8.9	14.8	19	10	12	10	13.8	12.8
Ann Arbor Staging	I	III	II	III	II	II	III	II
Systemic symptoms (A/B)	A	B	A	A	B	A	A	A
Inflammatory Syndrome (a/b)	b	b	b	b	b	a	b	a
WHO classification	ns	ns	ns	ns	ns	ns	ns	ns
MCNS remission	yes	yes	SRNS	yes	SRNS	SDNS	yes	SRNS
cHL remission	yes	yes	yes	yes	yes	yes	yes	yes

MCNS: Minimal change nephrotic syndrome; cHL: Classical Hodgkin lymphoma; ns: nodular sclerosis; SRNS: Steroid Resistant Nephrotic Syndrome; SD: Steroid Dependent Nephrotic Syndrome.